
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026

EORTC’s presence at ESTRO 2026
30 Apr 2026

Independent, academic cancer trials are vital to improve patient outcomes worldwide
28 Apr 2026

EORTC Imaging Group Becomes the Diagnostic and Therapeutic Imaging Group
24 Apr 2026

Investing in the future of cancer research; EORTC’s Young and Early Career investigator Network shows its value
23 Apr 2026

In Memoriam of Martine Van Glabbeke (1951-2026)
17 Apr 2026

PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases
27 Feb 2026

EORTC celebrates Rare Disease Day: Addressing unmet needs in rare cancers
27 Feb 2026